James C. Foster, Director at CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL), sold 75,000 shares at $225.00 ($16.9M) on 2026-06-29, disclosed to the SEC on 2026-07-01.
Scheduled sale ($16.9M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CRL | BUY | 2025-02-21 | $2.0M | — | Filing → |
| CRL | SELL | 2024-08-05 | $6.3M | — | Filing → |
| CRL | BUY | 2023-11-15 | $2.0M | — | Filing → |